Stroke Journal

FEBRUARY 1, 2024

vs. 6.9%, SD 0.1), chronic kidney disease (1.9% This finding sets the stage for future work leveraging both outpatient and pharmacy-based claims to further explore this finding. Patients with migraine were younger (40.2±15.2 standardized difference (SD) 0.38), more likely to be female (81.4% vs. 5.1%, SD 0.12).

Stroke 40

Stroke Strokes Document Kidney Disease 40

Stroke Journal

FEBRUARY 1, 2024

The ADA recommends in patients with ASCVD, when prevention of further vascular events is the priority, a GLP1RA should be added; and when concern for heart failure or chronic kidney disease is the priority, a SGLT2i should be added.Objective:Among a cohort of patients with diabetes presenting with AIS, we analyzed rates of GLP1RA and SGLT2i use during (..)

Diabetes 40

Diabetes Stroke Strokes Kidney Disease 40

Open Heart

JULY 17, 2023

to 5.12; p=0.049), chronic kidney disease (HR 1.89; 95% CI 1.03 to 3.49; p=0.041) as well as severe valvular heart disease (HR 3.08; 95% CI 1.68 Results The combined end point of death and emergency cardiovascular hospitalisation occurred in 70 (36.3%) of 193 patients with a postponed cardiovascular intervention.

COVID-19 52

COVID-19 Outcomes Cardiovascular Interventions Risk Factors 52

Open Heart

JULY 20, 2022

Outcome measures were (1) all-cause hospitalisations, (2) outpatient clinic attendances and (3) cost. post-MDT; p<0.001), initiation of renin–angiotensin aldosterone system inhibitors in HF with reduced ejection fraction (HFrEF) with advanced chronic kidney disease (9% pre vs 71% post-MDT; p<0.001). ±4 months.

Heart Failure 52

Heart Failure Kidney Disease Outpatient Nursing 52

DAIC

APRIL 30, 2024

The drug, dapagliflozin, was initially approved for the treatment of Type 2 diabetes, but it since has been shown to reduce the risk of hospitalization for heart failure and death in patients with serious health problems that include heart and chronic kidney disease and heightened cardiovascular risk.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105

Open Heart

SEPTEMBER 27, 2023

Background Heart failure (HF), type 2 diabetes (T2D) and chronic kidney disease (CKD) commonly coexist. In multivariable analyses, we identified risk factors for developing the third condition and mortality, such as age, sex, medical history and the order of disease diagnosis.

Risk Factors 52

Risk Factors Kidney Disease Heart Failure Diabetes 52

Open Heart

JUNE 16, 2022

Objective To investigate temporal trends of chronic kidney disease (CKD) among patients with incident aortic stenosis (AS) and to compare these trends with that of a matched control population. Dialysis subgroup had at least two outpatient billing codes of dialysis. Three subgroups were considered.

Kidney Disease 52

Kidney Disease Stenosis Aortic Outpatient 52